Ramucirumab Plus Pembrolizumab vs Usual Care for Treatment of Stage IV or Recurrent Non-Small Cell Lung Cancer Following Immunotherapy, Pragmatica-Lung Study
SWOG Cancer Research Network
SWOG Cancer Research Network
City of Hope Medical Center
SWOG Cancer Research Network
Pfizer
PrECOG, LLC.
Institut Paoli-Calmettes
Guangdong Provincial People's Hospital
Abramson Cancer Center at Penn Medicine
Fudan University
Fundación GECP
University of Washington
Sichuan University
Sichuan University
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Krystal Biotech, Inc.
University Hospital, Essen
Trans Tasman Radiation Oncology Group
Incyte Corporation
West China Hospital
Sun Yat-sen University
University of Kentucky